Zika virus and its implications on cord blood banking and transplantation.
Transfusion
; 60(5): 889-891, 2020 05.
Article
en En
| MEDLINE
| ID: mdl-32208533
ABSTRACT
Umbilical cord blood is an important cellular therapy product used for hematopoietic stem cell transplantation, but the US Food and Drug Administration guidance regarding donor screening to reduce the risk of Zika transmission has decreased the number of licensed, eligible cord blood units available for transplantation. There is a crucial need for updated travel risk assessment for Zika virus transmission, validated screening tests for Zika virus in umbilical cord blood, and further research on Zika virus transmissibility due to umbilical cord blood products to ensure that umbilical cord blood and related tissues are safe and available for transplantation.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Bancos de Sangre
/
Trasplante de Células Madre Hematopoyéticas
/
Trasplante de Células Madre de Sangre del Cordón Umbilical
/
Selección de Donante
/
Infección por el Virus Zika
/
Almacenamiento de Sangre
Tipo de estudio:
Etiology_studies
/
Guideline
/
Risk_factors_studies
Límite:
Female
/
Humans
/
Male
/
Newborn
/
Pregnancy
Idioma:
En
Revista:
Transfusion
Año:
2020
Tipo del documento:
Article
País de afiliación:
Estados Unidos